Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12250 from 12274 pages
No results were found for the filter!
AKR1C3-IN-8
AKR1C3-IN-8

Item number: TGM-T61926-100mg

Description: AKR1C3-IN-8 (Compound 5) is a potent and selective AKR1C3 inhibitor (IC50 = 0.069 µM) with demonstrated antitumor activity. Target: Others
MW: 400.43 D
From 1,440.00€ *
Review
hDDAH-1-IN-2 sulfate
hDDAH-1-IN-2 sulfate

Item number: TGM-T61927-100mg

Description: hDDAH-1-IN-2 is a selective, orally active inhibitor of [human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1)] with an excellent cell toxicity/viability profile. Target: Others
MW: 400.43 D
From 1,440.00€ *
Review
Topo I/COX-2-IN-1
Topo I/COX-2-IN-1

Item number: TGM-T61939-100mg

Description: Topo I/COX-2-IN-1 (1H-30) is a potent Topo I/COX-2 inhibitor with IC50 values of 0.24 µM for COX-2 and 4.42 µM for Topo I. It induces apoptosis and inhibits cancer cell migration, demonstrating anti-cancer activity. Target: Others
MW: 400.83 D
From 1,440.00€ *
Review
Tubulin polymerization-IN-4
Tubulin polymerization-IN-4

Item number: TGM-T61940-100mg

Description: Tubulin polymerization-IN-4 is an effective inhibitor of tubulin polymerization (IC50=4.6 µM)? Tubulin polymerization-IN-4 can destroy tubulin polymerization, block cell cycle at G2/M phase, induce apoptosis, and inhibit cell cloning and migration. Tubulin polymerization-IN-4 can also damage the...
MW: 400.86 D
From 1,440.00€ *
Review
VEGFR-2-IN-5 hydrochloride
VEGFR-2-IN-5 hydrochloride

Item number: TGM-T61943-100mg

Description: VEGFR-2-IN-5 hydrochloride is a potent inhibitor of VEGFR2. Target: Others
MW: 400.91 D
From 726.00€ *
Review
MraY-IN-2
MraY-IN-2

Item number: TGM-T61948-100mg

Description: MraY-IN-2 (compound 6) is a potent inhibitor of bacterial transposase MraY (IC50=4.5 µM), suitable for antibacterial research. Target: Others
MW: 401.37 D
From 1,440.00€ *
Review
MAO A/HDAC-IN-1
MAO A/HDAC-IN-1

Item number: TGM-T61958-100mg

Description: MAO A/HDAC-IN-1 is an effective dual inhibitor of monoamine oxidase A (MAO A) and HDAC, suitable for glioma research. Target: Others
MW: 401.89 D
From 1,440.00€ *
Review
PARP-1/HDAC-IN-1
PARP-1/HDAC-IN-1

Item number: TGM-T61962-10mg

Description: PARP-1/HDAC-IN-1 is an effective dual inhibitor of PARP-1 and HDAC6, with IC50 values of 68.90 nM and 510 nM, respectively. PARP-1/HDAC-IN-1 exhibits anti-cancer, anti-migration, and anti-angiogenesis activities. Target: HDAC, PARP, Others. Smiles:...
MW: 402.4 D
From 276.00€ *
Review
SphK1-IN-1
SphK1-IN-1

Item number: TGM-T61965-100mg

Description: SphK1-IN-1 is an inhibitor of SphK1 with anti-tumor activity. SphK1-IN-1 inhibits the ATPase of SphK1, IC50=2.48 µM. SphK1-IN-1 has the value of cancer research. Target: Others
MW: 402.45 D
From 1,440.00€ *
Review
Anticancer agent 79
Anticancer agent 79

Item number: TGM-T61973-100mg

Description: Anticancer agent 79 (compound 3d) is an anticancer compound with good anti-breast cancer activity, exhibiting cytotoxic activity in T47-D cells (IC50= 13.64 ± 0.26 µM). Target: Others
MW: 403.31 D
From 1,440.00€ *
Review
MEIS-IN-3
MEIS-IN-3

Item number: TGM-T62194-100mg

Description: MEIS-IN-3 is a potent MEIS inhibitor [(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-thiazol-2-yl-amine] with potential applications in cancer therapy. It exhibits high binding affinity and specificity, effectively blocking MEIS activity to inhibit tumor growth. Target: Others
MW: 418.48 D
From 1,440.00€ *
Review
Dyrk1A/alpha-synuclein-IN-2
Dyrk1A/alpha-synuclein-IN-2

Item number: TGM-T62226-100mg

Description: Dyrk1A/alpha-synuclein-IN-2 (Compound b20) is a dual inhibitor of Dyrk1A and alpha-synuclein aggregation with an IC50 of 7.8 µM for alpha-synuclein. It exhibits high predictive CNS permeability and has a neuroprotective effect. Target: Others
MW: 420.44 D
From 1,440.00€ *
Review
12250 from 12274 pages